Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01713569 · ClinicalTrials.gov registry record · NA

Feasibility Study: Histological Characterization After Treatment With the Ulthera® System

A NA study, sponsored by Ulthera.

Terminated
Registry status
NA
Development phase
2
Enrollment target

NCT01713569: Clinical Trial NA study, sponsored by Ulthera.

NCT01713569 is a NA study that was terminated before completion, run by Ulthera. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01713569, a NA study, was terminated before completion, sponsored by Ulthera.

TERMINATED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

Up to 6 subjects will be enrolled. Subjects who have already chosen to have a surgical facelift procedure will be enrolled. Subjects will receive selective Ulthera® ultrasound exposures in the pre-auricular regions. Subject will return for a follow-up visit up to 48 hours post-treatment, on the day of their rhytidectomy. Study images will be obtained pretreatment, immediately post-treatment, and at the follow-up visit.

Primary Outcome

Post-treatment, treated tissue will be resected for histological analysis.

Interventions

  • DEVICE Ulthera Treatment

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2012-10
Est. Completion 2013-10
Phase NA
Ulthera

42 total trials

Why NCT01713569 stopped before completion

NCT01713569 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Ulthera Treatment is the first listed.

NCT01713569 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01713569 about?

NCT01713569 is a clinical study titled "Feasibility Study: Histological Characterization After Treatment With the Ulthera® System". Up to 6 subjects will be enrolled. Subjects who have already chosen to have a surgical facelift procedure will be enrolled. Subjects will receive selective Ulthera® ultrasound exposures in the pre-auricular regions. Subject will return for a follow-up visit up to 48 hours post-treatment, on the day ...

What is the current status of trial NCT01713569?

This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2012-10. Estimated completion is 2013-10.

What interventions are being tested in trial NCT01713569?

The interventions under investigation include: Ulthera Treatment (DEVICE).

Who is sponsoring clinical trial NCT01713569?

This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01713569's enrollment target sits among peer trials

2 1997th of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01713569, the US trial registry maintained by the National Library of Medicine. NCT01713569 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.